Actual Medicinal Product (AMP) Keppra 250mg tablets (UCB Pharma Ltd)
Stability Information
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No special requirements for storage.
- Generic
- Levetiracetam
- Formulation
- Levetiracetam 250mg tablets
-
Levetiracetam
-
Levetiracetam 250mg tablets
-
Keppra 250mg tablets (UCB Pharma Ltd)
-
-
Keppra 250mg tablets (DE Pharmaceuticals)
Levetiracetam 250mg tablets (Milpharm Ltd)